How Do You Evaluate Formulation Management Software?

Why do Formulation Software evaluations go wrong?
What are the Six Evaluation Dimensions?
What three questions should you ask in the demonstration?
Frequently Asked Questions

**TL;DR**
Evaluate formulation management software across six dimensions: technical capabilities, functional capabilities, execution and support services, product vision and strategy, corporate strategy, and customer base. Weight current capability and future direction equally. Before scoring anything, disqualify the systems that are not in the category — MES, laboratory information systems, automation and generic ERP without formulation logic. Then test three things in the demonstration: what happens when a regulation changes, when R&D approves a formula, and when a supplier sends a specification.

Why Do Formulation Software Evaluations Go Wrong?

**Key Takeaway**
Most evaluations fail on scope, not on scoring. Adjacent systems — MES, LIMS, automation, generic ERP — answer a formulation brief convincingly in a demonstration and reveal the gap during implementation. Establish the category boundary before you build the shortlist.

The common failure is not choosing the wrong vendor from a good shortlist. It is building a shortlist of systems that were never in the category.

When ARC Advisory Group defined formulation management software in 2026, it drew explicit boundaries. Manufacturing execution systems run production but do not develop formulas. Laboratory information systems manage samples and results, not the formula lifecycle. Equipment control and automation solve a different problem. Generic ERP without formulation logic knows a bill of materials but cannot evaluate what an ingredient substitution does to an allergen declaration or a cost threshold.

ARC Advisory Group is an independent research and advisory firm founded in 1986, covering technology for industrial, energy and infrastructure markets. Its analysts assess software and automation vendors across manufacturing sectors.

Any of these can demonstrate well against a loosely written brief. Rule them in or out first.

What Are the Six Evaluation Dimensions?

**Key Takeaway**
ARC scores vendors in this market across six dimensions, split evenly between what a platform does today — technical capabilities, functional capabilities, execution and support services — and where it is going — product vision and strategy, corporate strategy, and customer base. The same six work as a buyer's framework.

These are the dimensions ARC Advisory Group used to assess 17 providers in its 2026 MarketMap for Formulation Technologies. They translate directly into a buyer's checklist.

1. Technical capabilities

Architecture, scalability and deployment options, including data residency by region
Security, access control and audit trail depth
Interoperability: what integrates natively, what needs custom development
AI capabilities in production today, distinct from roadmap
How far the system configures without code, and who is able to configure it

2. Functional capabilities

Formulation and recipe creation: ingredient management, compatibility, stability, iteration across trials
Governance: change control, versioning, audit trails, regulatory documentation
Regulatory intelligence: which markets, how it is maintained, how often it updates
Labeling and specification output, including multi-product formats
Supplier collaboration: specification exchange, compliance documentation, certificates of analysis

3. Execution and support services

Implementation methodology and typical timeline for a comparable deployment
Service coverage in every region you operate in, and in which languages
Ratio of configuration to custom development in recent implementations
Who performs the work: vendor, partner, or your team

4. Product vision and strategy

Published roadmap, and what shipped from the last two roadmaps
Direction on AI: which capabilities are live, which are announced
Position on emerging requirements such as digital product passports and lifecycle assessment

5. Corporate strategy

Financial stability and ownership structure
Acquisition history and how acquired products were integrated
Whether your industry is a core market or an adjacent one

6. Customer base

Reference customers of comparable size, complexity and market footprint
Retention, and the reasons customers have left
Whether references are using the modules you are buying, in the regions you operate in

ARC weights current capability and future direction equally. Whether that balance is right for you depends on your timeline. A buyer replacing a failing system weights capability higher. A buyer making a ten-year platform decision does not.

See how 17 providers scored against these dimensions.

The abbreviated ARC MarketMap includes the supplier scoring heat map, rating every provider across all six.

What Three Questions Should You Ask in the Demonstration?

**Key Takeaway**
Three scenarios separate platforms that manage formulation from platforms that only store it: a regulatory change, an approved formula moving to manufacturing, and an incoming supplier specification. Ask the vendor to perform each one live rather than describe it.

1. A regulator restricts an ingredient today. Show me every affected product, in every market, and the labels that now need amending.

A formulation platform answers with a portfolio query. Everything else answers by describing a report you would build yourself.

2. R&D has just approved a reformulated product. Show me what manufacturing receives, and how.

This is where formulation data is most often lost and where rework originates. Watch for the word "export."

3. A supplier has sent a new raw material specification. Show me what happens to it.

The answer is either that the system reads and structures it, or that a person retypes it. Both are legitimate answers. Only one scales.

Ask for these live, on the vendor's own demonstration data. A vendor that cannot perform them in a demonstration will not perform them in production.

What Are the Red Flags?

Regulatory content is a static database rather than a maintained service, with no stated update cadence
Every reference customer is in a different industry or an order of magnitude smaller than you
AI capability is described entirely in future tense
The implementation estimate assumes no integration work
The demonstration environment cannot be shown with your own sample formula
Nobody can tell you what happens on the day a regulation changes

Run this framework across your shortlist.

The formulation software vendor scorecard adds a weighted scoring sheet, a scope check to disqualify adjacent systems, and a demonstration script:

What criteria should I use to evaluate formulation software?

Six dimensions: technical capabilities, functional capabilities, execution and support services, product vision and strategy, corporate strategy, and customer base. These are the dimensions ARC Advisory Group applied across 17 providers in its 2026 MarketMap for Formulation Technologies.

How long does a formulation software evaluation take?

Timelines vary with portfolio complexity and the number of markets involved. The variable that most often extends an evaluation is scope: shortlists that mix formulation platforms with ERP, MES or LIMS take longer because the systems are not comparable.

Should I evaluate formulation software separately from PLM?

It depends on whether you need formulation science or lifecycle governance. Some platforms deliver both. Generic PLM built for discrete manufacturing does not understand formulation logic, which is why ARC treats formulation management software as a distinct category.

What is the biggest hidden cost in a formulation software implementation?

Integration and configuration, not licensing. Ask every vendor for the ratio of configuration to custom development in their three most recent comparable implementations.